Found 894 matching trials
Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer PHASE2 Background:
-This study uses an experimental cancer treatment that uses th...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer PHASE2 RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors PHASE2 Objectives of the study:
This randomized multicenter phase II study compar...
Show More Location
Free University Hospital
Learn More & Join Trial
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma PHASE1 RATIONALE: Giving high-dose chemotherapy drugs, such as carmustine, etoposi...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer PHASE3 A randomized multi-arm study evaluating the efficacy and safety of nivoluma...
Show More Location
Local Institution - 0136
Learn More & Join Trial
Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells PHASE1 Patients eligible for this study have a type of blood cancer called T-cell ...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
Rescue of Nephrons With ALE.F02 (RENAL-F02) PHASE2 The goal of this clinical trial is to learn if a new drug that might help p...
Show More Location
Vseobecna fakultni nemocnice v Praze
Learn More & Join Trial
T Cells Expressing a Bispecific CAR Targeting CS1 and BCMA in Relapsed/Refractory Multiple Myeloma PHASE1 This is a single-center, open-label, single-arm study to evaluate the safet...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma PHASE1 Single center, phase I/II randomized 2-arm study, evaluating two different ...
Show More Location
Multiple Locations
Learn More & Join Trial